|
|
|
Insider
Information: |
Boulding Mark Elliott |
Relationship: |
|
City: |
South Plainfield |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
92,389 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,411,926 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
92,389 |
|
|
Total
Value |
$3,411,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-136.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
92,389 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2021-01-05 |
4 |
S |
$62.37 |
$48,150 |
D/D |
(772) |
38,952 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2021-02-01 |
4 |
S |
$56.96 |
$44,312 |
D/D |
(778) |
48,374 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2022-01-07 |
4 |
S |
$38.53 |
$34,095 |
D/D |
(885) |
47,489 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2022-02-01 |
4 |
S |
$40.00 |
$31,162 |
D/D |
(779) |
61,110 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2023-01-09 |
4 |
S |
$41.66 |
$34,783 |
D/D |
(835) |
77,275 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2023-01-10 |
4 |
S |
$42.93 |
$25,330 |
D/D |
(590) |
76,685 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2023-01-11 |
4 |
S |
$44.36 |
$21,958 |
D/D |
(495) |
76,190 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2023-01-31 |
4 |
S |
$45.63 |
$37,050 |
D/D |
(812) |
75,378 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2024-01-08 |
4 |
S |
$28.64 |
$41,729 |
D/D |
(1,457) |
73,921 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2024-01-09 |
4 |
S |
$29.01 |
$56,231 |
D/D |
(1,938) |
71,983 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2024-01-30 |
4 |
S |
$27.25 |
$21,637 |
D/D |
(794) |
71,189 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Exec VP and CLO |
|
2015-06-08 |
4 |
OE |
$10.85 |
$673,601 |
D/D |
62,083 |
73,176 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2019-06-28 |
4 |
OE |
$10.85 |
$880,723 |
D/D |
77,575 |
30,664 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2019-07-01 |
4 |
OE |
$10.85 |
$2,521,639 |
D/D |
104,092 |
47,024 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2019-07-05 |
4 |
OE |
$11.23 |
$231,279 |
D/D |
15,312 |
33,899 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2020-07-07 |
4 |
OE |
$11.23 |
$462,569 |
D/D |
30,625 |
57,224 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2021-07-08 |
4 |
OE |
$11.23 |
$127,008 |
D/D |
7,805 |
49,779 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2021-07-09 |
4 |
OE |
$18.01 |
$25,736 |
D/D |
1,429 |
48,618 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2021-09-02 |
4 |
OE |
$18.01 |
$60,568 |
D/D |
3,363 |
51,737 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
|
2022-02-10 |
4 |
OE |
$11.23 |
$307,537 |
D/D |
17,935 |
76,763 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2022-04-05 |
4 |
OE |
$11.23 |
$56 |
D/D |
5 |
61,115 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2022-09-20 |
4 |
OE |
$30.86 |
$36,291 |
D/D |
1,176 |
61,410 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2022-10-17 |
4 |
OE |
$30.86 |
$203,738 |
D/D |
6,602 |
67,512 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2022-10-18 |
4 |
OE |
$30.86 |
$9,227 |
D/D |
299 |
61,399 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
|
2023-04-17 |
4 |
OE |
$30.86 |
$1,910,944 |
D/D |
61,923 |
134,009 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|